Early medication combination to reduce swelling after a brain bleed
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether giving a combination of blood-pressure-lowering medicines early after a brain bleed can reduce swelling and improve recovery. It aims to start treatment within 3 days of the bleed to see if it helps limit brain damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have had a recent bleed in the brain (within the last 3 days).
- The bleed is not caused by injury or other conditions like a burst blood vessel or a tumor.
- The size of the bleed, seen on a CT scan, is at least about the size of a small egg.
- You are not planning to have surgery to remove the blood.
- You do not have asthma, a very slow heart rate, or other conditions that would make the study drugs unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how inflammation and the brain's protective barrier are affected after a hemorrhagic stroke. It uses special brain scans to see these changes, which might help guide future care.
This trial tests a drug called propranolol, usually used for blood pressure, to see if it can prevent a complication called SAP (stroke-associated pneumonia) in people who have had a bleeding stroke. The drug is given through an IV within 24 hours of stroke onset.
This study collects blood samples from people with and without bleeding risk to test a clot-dissolving drug (tPA) outside the body. It aims to improve minimally invasive surgery for brain hemorrhages.
This study tests two sedative medications, remifentanil and dexmedetomidine, to lower blood pressure quickly after a brain bleed (intracerebral hemorrhage). High blood pressure right after a bleed can cause more damage, so this trial aims to see if these drugs help improve recovery.
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
This trial tests a combination of medicines given early after a large ischemic stroke to reduce brain swelling. It may help people who have had a stroke in the middle cerebral artery within the last 3 days and have a large area of brain damage.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.